Knott David M Jr Day One Biopharmaceuticals, Inc. Transaction History
Knott David M Jr
- $158 Million
- Q2 2025
A detailed history of Knott David M Jr transactions in Day One Biopharmaceuticals, Inc. stock. As of the latest transaction made, Knott David M Jr holds 33,714 shares of DAWN stock, worth $246,112. This represents 0.14% of its overall portfolio holdings.
Number of Shares
33,714Holding current value
$246,112% of portfolio
0.14%Shares
1 transactions
Others Institutions Holding DAWN
# of Institutions
182Shares Held
70.6MCall Options Held
122KPut Options Held
85.5K-
Atlas Venture Life Science Advisors, LLC6.43MShares$46.9 Million9.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.18MShares$45.1 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.53MShares$33.1 Million0.0% of portfolio
-
Franklin Resources Inc San Mateo, CA4.1MShares$29.9 Million0.01% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.72MShares$27.2 Million0.56% of portfolio
About Day One Biopharmaceuticals, Inc.
- Ticker DAWN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 73,461,104
- Market Cap $536M
- Description
- Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric pa...